Optimas Capital LTD Merck & Co., Inc. Transaction History

Optimas Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$123.8 - $132.96 $6.4 Million - $6.88 Million	51,735 Added 86.42%	111,600 $13.8 Million
Q1 2024 May 07, 2024	BUY	$113.24 - $131.95 $4.21 Million - $4.9 Million	37,165 Added 163.72%	59,865 $7.9 Million
Q4 2023 Jan 22, 2024	BUY	$100.18 - $109.02 $42,977 - $46,769	429 Added 1.93%	22,700 $2.47 Million
Q3 2023 Oct 30, 2023	SELL	$102.95 - $114.33 $939,830 - $1.04 Million	-9,129 Reduced 29.07%	22,271 $2.29 Million
Q2 2023 Aug 11, 2023	BUY	$108.61 - $118.38 $3.41 Million - $3.72 Million	31,400 New	31,400 $3.62 Million

3,819

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $247B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Optimas Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Optimas Capital LTD with notifications on news.